Pharmacovigilance refers to monitoring of drug safety, detection, assessment, understanding and prevention of adverse effects or any other drug-related problems after the marketing authorisation or approval of medicines and medical devices. Stringent regulations imposed by regulatory bodies across the world has made pharmacovigilance an important activity throughout the drug development and post-marketing surveillance.
The global pharmacovigilance market is estimated to be valued at US$ 179.62 Bn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the pharmacovigilance marketare Collibra NV, SAP SE, SAS Institute Inc., Symantec Corporation (NortonLifelock), TIBCO Software Inc., Informatica Inc., Alation Inc., IBMCorporation, Varonis Systems Inc., Alfresco Software Inc., Oracle Corporation,Talend SA and Microsoft Corporation. These key players are involved in variousactivities including clinical trial monitoring and post-marketing surveillanceto ensure drug safety. They hold a major share in the global owing to strong product portfolio and global presence.
YOU ARE READING
Pharmacovigilance Market
ActionPharmacovigilance refers to monitoring of drug safety, detection, assessment, understanding and prevention of adverse effects or any other drug-related problems after the marketing authorisation or approval of medicines and medical devices. Stringen...
